Equities

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.05
  • Today's Change0.11 / 2.23%
  • Shares traded362.30k
  • 1 Year change+43.87%
  • Beta0.7443
Data delayed at least 15 minutes, as of Nov 22 2024 20:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue193254269
OPERATING EXPENSES
Cost of revenue total152426
Selling, general and admin. expenses, total113136124
Depreciation/amortization2.091.521.48
Unusual expense(income)----20
Other operating expenses, total------
Total operating expense207248227
Operating income(14)6.3342
Other, net204.970.20
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6.341142
Provision for income taxes3.835.039.21
Net income after taxes2.516.2833
Minority interest------
Net income before extra. Items2.516.2833
Total extraordinary items------
Net income2.516.2833
Inc.avail. to common excl. extra. Items2.516.2833
Inc.avail. to common incl. extra. Items2.516.2833
EPS RECONCILIATION
Basic/primary weighted average shares575656
Basic/primary eps excl. extra items0.040.110.60
Basic/primary eps incl. extra items0.040.110.60
Dilution adjustment------
Diluted weighted average shares585757
Diluted eps excl. extra items0.040.110.58
Diluted eps incl. extra items0.040.110.58
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental0.921.221.40
Total special items----20
NORMALISED INCOME
Normalized income before taxes6.341162
Effect of special items on income taxes----4.31
Income tax excluding impact of special items3.835.0314
Normalized income after tax2.516.2849
Normalized income avail. to common2.516.2849
Basic normalized EPS0.040.110.88
Diluted normalized EPS0.040.110.85
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.